Moderna, Inc. (MRNA)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS60770K1079
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Moderna, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:57. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 12 Feb 2027 08:00 | -2.15 | — | — | Upcoming |
| 06 Nov 2026 06:00 | -1.25 | 0.38 | +130.3% | Beat |
| 31 Jul 2026 07:00 | -2.06 | -1.97 | +4.3% | Beat |
| 30 Apr 2026 20:00 | -3.88 | -3.40 | +12.4% | Beat |
| 13 Feb 2026 07:00 | -2.64 | -2.11 | +20.2% | Beat |
| 06 Nov 2025 07:00 | -2.16 | -0.51 | +76.4% | Beat |
| 01 Aug 2025 07:00 | -3.00 | -2.13 | +29.0% | Beat |
| 01 May 2025 06:00 | -3.11 | -2.52 | +18.9% | Beat |
| 14 Feb 2025 06:00 | -2.73 | -2.91 | -6.7% | Miss |
| 07 Nov 2024 06:00 | -1.94 | 0.03 | +101.6% | Beat |
| 01 Aug 2024 06:00 | -3.35 | -3.33 | +0.7% | In line |
| 02 May 2024 06:00 | -3.57 | -3.07 | +14.1% | Beat |
| 22 Feb 2024 06:00 | -0.99 | 0.55 | +155.6% | Beat |
| 02 Nov 2023 06:00 | -2.05 | -9.53 | -364.4% | Miss |
| 03 Aug 2023 06:00 | -4.12 | -3.62 | +12.2% | Beat |
| 04 May 2023 16:00 | -1.73 | 0.19 | +111.0% | Beat |
| 23 Feb 2023 07:00 | 4.60 | 3.61 | -21.5% | Miss |
| 03 Nov 2022 07:00 | 3.11 | 2.53 | -18.6% | Miss |
| 03 Aug 2022 07:00 | 4.49 | 5.24 | +16.6% | Beat |
| 04 May 2022 06:00 | 5.62 | 8.58 | +52.6% | Beat |
| 24 Feb 2022 06:00 | 9.81 | 11.29 | +15.1% | Beat |
| 04 Nov 2021 07:00 | 9.42 | 7.70 | -18.3% | Miss |
| 05 Aug 2021 06:00 | 5.86 | 6.46 | +10.3% | Beat |
| 06 May 2021 07:00 | 2.47 | 2.84 | +15.1% | Beat |
| 25 Feb 2021 07:00 | -0.36 | -0.69 | -89.6% | Miss |
| 29 Oct 2020 07:00 | -0.37 | -0.59 | -60.4% | Miss |
| 05 Aug 2020 07:00 | -0.36 | -0.31 | +14.6% | Beat |
| 07 May 2020 08:00 | -0.36 | -0.35 | +3.8% | Beat |
| 26 Feb 2020 07:00 | -0.42 | -0.37 | +12.2% | Beat |
| 06 Nov 2019 16:00 | -0.44 | -0.37 | +15.6% | Beat |
| 08 Aug 2019 16:00 | -0.45 | -0.41 | +8.9% | Beat |
| 09 May 2019 16:00 | -0.36 | -0.40 | -9.7% | Miss |
| 13 Mar 2019 16:00 | -0.36 | -0.44 | -23.0% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 1.9B | -39.9% | -2.8B | -146.8% | -7.26 | +21.8% | -2.1B |
| 2024 | 3.2B | -52.6% | -3.6B | -111.3% | -9.28 | +24.7% | -4.1B |
| 2023 | 6.8B | -64.2% | -4.7B | -69.8% | -12.33 | -161.3% | -3.8B |
| 2022 | 18.9B | — | 8.4B | 44.3% | 20.12 | — | 4.6B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 224.16 | 280.80 | 217.62 | 225.89 | +1.88% | 102,634,769 | |
| Oct 2026 | 186.61 | 254.48 | 179.53 | 221.72 | +15.14% | 416,218,700 | |
| Sep 2026 | 140.25 | 208.90 | 130.38 | 192.57 | +37.22% | 321,125,600 | |
| Aug 2026 | 54.92 | 176.66 | 52.66 | 140.34 | +156.00% | 625,584,200 | |
| Jul 2026 | 70.04 | 85.60 | 53.35 | 54.82 | -21.72% | 146,821,000 | |
| Jun 2026 | 47.07 | 73.28 | 43.90 | 70.03 | +48.40% | 180,103,000 | |
| May 2026 | 46.63 | 59.48 | 43.68 | 47.19 | +2.72% | 158,425,800 | |
| Apr 2026 | 51.64 | 56.20 | 44.62 | 45.94 | -9.57% | 116,299,600 | |
| Mar 2026 | 52.42 | 59.55 | 47.14 | 50.80 | -5.17% | 190,289,600 | |
| Feb 2026 | 43.45 | 54.02 | 36.65 | 53.57 | +21.56% | 196,520,800 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- GSK (LSE:GSK) Settles Key Vaccine Patent Case And Wins Broad Europe Injunction (opens in a new tab) Simply Wall St. · 13 Nov 2026 01:18
- BioNTech May Be the Next Moderna. Even if it Isn’t, the Stock Is a Buy. (opens in a new tab) Barrons.com · 13 Nov 2026 01:02
- Moderna Targets 2027 Cancer Therapy Launch, Raises 2026 Revenue Growth Outlook (opens in a new tab) MarketBeat · 12 Nov 2026 22:14
- Moderna Needs a Post-Covid Hit. Its Cancer-Drug Spending Plan Ups the Stakes. (opens in a new tab) Barrons.com · 12 Nov 2026 21:29
- Moderna Sinks 7% as Analyst Day Cancer Push Brings “$4 Billion in Cash Costs in 2027” (opens in a new tab) TIKR · 12 Nov 2026 19:38
- Why Is Moderna (MRNA) Joining A Global Benchmark And Publishing New Vaccine Data? (opens in a new tab) Simply Wall St. · 12 Nov 2026 19:10
- Why Moderna Stock Dropped on Thursday (opens in a new tab) Motley Fool · 12 Nov 2026 17:33
- Health Care Roundup: Market Talk (opens in a new tab) The Wall Street Journal · 12 Nov 2026 17:26
- MRNA Stock Up 3% Since Q3 Earnings Release: How to Play the Stock? (opens in a new tab) Zacks · 12 Nov 2026 16:53
- Moderna Raises 2026 Revenue Growth Forecast to 15%–25% and Reports Progress in Cancer Vaccine Development (opens in a new tab) InvestorsHub · 12 Nov 2026 13:26
- Moderna Outlines Next Phase of Growth at Analyst Day (opens in a new tab) 12 Nov 2026 12:00
- What Invesco S&P 500 Equal Weight ETF (RSP) Bought: Moderna Leads on Nov. 10 (opens in a new tab) GuruFocus.com · 12 Nov 2026 11:04
- Moderna Raises FY26 Sales Growth Guidance To 15%-25% From 10%; On Track To Achieve FY26 Gross Margin Expansion Of ~10 Percentage Points Excluding Litigation Settlement Charge; Expects Annual Cash Costs Of ~$4B-$4.5B Over 2027-2030; Sees Ending 2026 With ~$9B In Total Liquidity, Including Cash, Inve… (opens in a new tab) Benzinga · 12 Nov 2026 08:30
- Moderna Announces JAMA Network Open Publication of Real-World Comparative Effectiveness Data for mNEXSPIKE (COVID-19 Vaccine, mRNA) in Adults Aged 65 Years and Older (opens in a new tab) 11 Nov 2026 16:10
- Moderna Stock Jumped 10% in 5 Sessions: Take Profits, or Buy More? (opens in a new tab) TIKR · 11 Nov 2026 13:39
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 231.35 USD
- Market cap
- 91.4B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow MRNA and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.